Representative William R Keating Stocks

On March 24, 2025, Representative William R Keating of US Congress acquired under $15k worth of JPMorgan Chase's common stock. Such disclosures are part of transparency measures that require elected officials to report their investments, ensuring public awareness and preventing conflicts of interest. Below are 24 other transactions of William R Keating.
2025-03-24Acquired Under $15KJPM JPMorgan ChaseInsidersVerify
2025-02-26Acquired Under $15KPEP PepsiCoInsidersVerify
2025-01-16Acquired Under $15KFI Fiserv,InsidersVerify
2024-11-06Acquired Under $15KLOW Lowes CompaniesInsidersVerify
2024-09-25Acquired Under $15KJPM JPMorgan ChaseInsidersVerify
2024-06-21Acquired $15K to $50KC CitigroupInsidersVerify
2024-05-22Acquired Under $15KLOW Lowes CompaniesInsidersVerify
2024-03-12Acquired Under $15KBA BoeingInsidersVerify
2024-02-05Acquired $15K to $50KT ATT IncInsidersVerify
2024-01-16Acquired $15K to $50KSPG Simon Property GroupInsidersVerify
2023-09-28Acquired $0 - $1,000CAT CaterpillarInsidersVerify
2023-08-28Acquired $15K to $50KPEP PepsiCoInsidersVerify
2023-07-31Acquired Under $15KISRG Intuitive SurgicalInsidersVerify
2023-07-19Acquired Under $15KCOF Capital One FinancialInsidersVerify
2023-06-15Acquired Under $15KCVS CVS Health CorpInsidersVerify
2023-02-28Acquired Under $15KJPM JPMorgan ChaseInsidersVerify
2023-01-30Acquired Under $15KBKNG Booking HoldingsInsidersVerify
2022-12-21Acquired Under $15KBAX Baxter InternationalInsidersVerify
2022-11-21Acquired Under $15KNOW ServiceNowInsidersVerify
2022-10-30Acquired $15K to $50KVZ Verizon CommunicationsInsidersVerify
2022-05-05Acquired Under $15KVRTX Vertex PharmaceuticalsInsidersVerify
2022-02-28Acquired $15K to $50KCMCSA Comcast CorpInsidersVerify
2021-07-20Acquired Under $15KVRSN VeriSignInsidersVerify
2021-04-27Acquired Under $15KJPM JPMorgan ChaseInsidersVerify
View All Elective Officials  

Risk-return Landscape of William R Keating's positions

  Expected Return   
       Risk  

Assets Rated by Market Efficiency

Many investors optimize their portfolios to maintain a risk-return balance that meets their personal investing preferences and liquidity needs. Understanding the relationship between the Sharpe ratio, risk, and expected return will help you build an optimal portfolio from your selected positions. Below are the essential efficiency ratios that can help you quickly create a reliable input to your portfolio optimization process.
EfficiencyMarket RiskExp ReturnPrice
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.